Zdrowie i gospodarka · 08/06/2009
FDA Requests Public Comment on Proposed Collection of User Fee Information
The Food and Drug Administration is seeking public input on a proposed collection of information related to user fees for certain drug and biologic product applications and supplements, as required by the Paperwork Reduction Act of 1995.